Reynoso Jamie L.'s Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed Jan 20, 2026
- Accession no.
- 0001801170-26-000024
- Filed
- Jan 20, 2026
- Trade date
- Jan 15-20, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $11.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reynoso Jamie L.CIK 0001839066 | Officer (CEO, Medicare Advantage) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Class A Common Stock | FTax withholdingDisposed | −14,732 | $2.81 | −$41,396.92 | 2,742,297 | Direct | |
| Jan 20, 2026 | Class A Common Stock | SSaleDisposed | −4,597 | $2.58 | −$11,860.26 | 2,737,700 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.